Pharmaceutical The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund), and Panacea Biotec, an Indian vaccine and pharmaceutical producers, have announced a collaboration to produce 100 million doses per year of Sputnik V, the COVID-19 vaccine developed by Russia’s Gamaleya National Center of Epidemiology and Microbiology. 5 April 2021